Dermatory

Dermatory arrived in 2018 as Clio Cosmetics' answer to a gap in its own portfolio: the makeup-led Korean group, already known for Clio and Peripera, had no dedicated line for reactive, sensitive skin. Built around a hypoallergenic premise, Dermatory leans on a 'tested ten times' messaging approach and formulations that exclude common irritants such as talc, sulfates, parabens, and synthetic fragrance. The range spans the categories seen in its catalog here, including the Allantoin Hypoallergenic Moisturizing line of creams, toners and pads, and the Hyal Shot barrier ampoules built around hyaluronic acid and panthenol. As a skin-care extension of a publicly traded cosmetics company, Dermatory has become a meaningful contributor to Clio's growth, with the parent crediting its derma lines for boosting overall profitability. It is manufactured in South Korea. As a brand that is still under a decade old, Dermatory does not carry the deep clinical literature of legacy derma houses; its appeal is built on accessible, barrier-focused formulas and the distribution muscle of an established Korean beauty group rather than on independent peer-reviewed research.